GlassScriptPhysician profile
Stephanie Iusim
NPI 1558756320
$957.42
in general payments reported to CMS, 2019-2025
17 companies · $23.29 in 2025
The $23.29 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.12 · 2022: $477 · 2023: $228 · 2024: $185 · 2025: $23.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.80 | 2021-2023 | Spiriva Respimat, Stiolto Respimat |
| Electromed, INC. | $150.39 | 2024 | Smartvest |
| United Therapeutics Corporation | $133.35 | 2022-2023 | Remodulin, Orenitram |
| Regeneron Healthcare Solutions, INC. | $68.62 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.01 | 2022-2023 | Glassia |
| Astrazeneca Pharmaceuticals LP | $50.51 | 2022-2023 | Fasenra |
| Glaxosmithkline, LLC. | $36.45 | 2022 | |
| Baxter Healthcare | $34.39 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Hospital Products INC. | $34.03 | 2022 | |
| Grifols USA, LLC | $23.29 | 2025 | Prolastin-C Liquid |
| Pinnacle Biologics, INC | $22.24 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $21.52 | 2022 | |
| Advanced Respiratory, INC | $20.29 | 2021 | |
| Mylan Specialty L.P. | $16.63 | 2022 | |
| Paratek Pharmaceuticals, INC. | $15.95 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $14.64 | 2023 | Purified Cortrophin Gel |
| Genzyme Corporation | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Iusim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.